These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 21664042

  • 21. Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.
    Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S, Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M.
    Oncol Rep; 2011 Jun; 25(6):1661-8. PubMed ID: 21479368
    [Abstract] [Full Text] [Related]

  • 22. Age-dependent regulation of tumor-related microRNAs in the brain of the annual fish Nothobranchius furzeri.
    Baumgart M, Groth M, Priebe S, Appelt J, Guthke R, Platzer M, Cellerino A.
    Mech Ageing Dev; 2012 May; 133(5):226-33. PubMed ID: 22487494
    [Abstract] [Full Text] [Related]

  • 23. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M.
    Cancer Res; 2010 Mar 15; 70(6):2339-49. PubMed ID: 20215506
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA (miRNA) expression profiling of peripheral blood samples in multiple myeloma patients using microarray.
    Yyusnita, Norsiah, Zakiah I, Chang KM, Purushotaman VS, Zubaidah Z, Jamal R.
    Malays J Pathol; 2012 Dec 15; 34(2):133-43. PubMed ID: 23424776
    [Abstract] [Full Text] [Related]

  • 25. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer.
    Valladares-Ayerbes M, Blanco M, Haz M, Medina V, Iglesias-Díaz P, Lorenzo-Patiño MJ, Reboredo M, Santamarina I, Figueroa A, Antón-Aparicio LM, Calvo L.
    Int J Oncol; 2011 Nov 15; 39(5):1253-64. PubMed ID: 21743960
    [Abstract] [Full Text] [Related]

  • 26. Genome-wide microRNA expression profiling in renal cell carcinoma: significant down-regulation of miR-141 and miR-200c.
    Nakada C, Matsuura K, Tsukamoto Y, Tanigawa M, Yoshimoto T, Narimatsu T, Nguyen LT, Hijiya N, Uchida T, Sato F, Mimata H, Seto M, Moriyama M.
    J Pathol; 2008 Dec 15; 216(4):418-27. PubMed ID: 18925646
    [Abstract] [Full Text] [Related]

  • 27. Expression and function of miR-27b in human glioma.
    Chen L, Li H, Han L, Zhang K, Wang G, Wang Y, Liu Y, Zheng Y, Jiang T, Pu P, Jiang C, Kang C.
    Oncol Rep; 2011 Dec 15; 26(6):1617-21. PubMed ID: 21922148
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, Nikitin AY.
    Cancer Res; 2007 Sep 15; 67(18):8433-8. PubMed ID: 17823410
    [Abstract] [Full Text] [Related]

  • 29. MicroRNAs: predictors and modifiers of chemo- and radiotherapy in different tumour types.
    Hummel R, Hussey DJ, Haier J.
    Eur J Cancer; 2010 Jan 15; 46(2):298-311. PubMed ID: 19948396
    [Abstract] [Full Text] [Related]

  • 30. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC.
    Zhao ZN, Bai JX, Zhou Q, Yan B, Qin WW, Jia LT, Meng YL, Jin BQ, Yao LB, Wang T, Yang AG.
    PLoS One; 2012 Jan 15; 7(9):e45133. PubMed ID: 23028803
    [Abstract] [Full Text] [Related]

  • 31. miR-23b/SP1/c-myc forms a feed-forward loop supporting multiple myeloma cell growth.
    Fulciniti M, Amodio N, Bandi RL, Cagnetta A, Samur MK, Acharya C, Prabhala R, D'Aquila P, Bellizzi D, Passarino G, Adamia S, Neri A, Hunter ZR, Treon SP, Anderson KC, Tassone P, Munshi NC.
    Blood Cancer J; 2016 Jan 15; 6(1):e380. PubMed ID: 26771806
    [Abstract] [Full Text] [Related]

  • 32. MiR-15a, miR-16-1 and miR-17-92 cluster expression are linked to poor prognosis in multiple myeloma.
    Gao X, Zhang R, Qu X, Zhao M, Zhang S, Wu H, Jianyong L, Chen L.
    Leuk Res; 2012 Dec 15; 36(12):1505-9. PubMed ID: 22959509
    [Abstract] [Full Text] [Related]

  • 33. A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.
    Streicher KL, Zhu W, Lehmann KP, Georgantas RW, Morehouse CA, Brohawn P, Carrasco RA, Xiao Z, Tice DA, Higgs BW, Richman L, Jallal B, Ranade K, Yao Y.
    Oncogene; 2012 Mar 22; 31(12):1558-70. PubMed ID: 21860416
    [Abstract] [Full Text] [Related]

  • 34. Bone morphogenetic proteins induce apoptosis in multiple myeloma cells by Smad-dependent repression of MYC.
    Holien T, Våtsveen TK, Hella H, Rampa C, Brede G, Grøseth LA, Rekvig M, Børset M, Standal T, Waage A, Sundan A.
    Leukemia; 2012 May 22; 26(5):1073-80. PubMed ID: 21941367
    [Abstract] [Full Text] [Related]

  • 35. miR-320a regulates cell proliferation and apoptosis in multiple myeloma by targeting pre-B-cell leukemia transcription factor 3.
    Lu Y, Wu D, Wang J, Li Y, Chai X, Kang Q.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):1315-1320. PubMed ID: 27086852
    [Abstract] [Full Text] [Related]

  • 36. Signal pathways, diseases, and functions associated with the miR-19a/92a cluster and the use of berberine to modulate the expression of this cluster in multiple myeloma cells.
    Yin Z, Yang J, Ning R, Liu Y, Feng M, Gu C, Fei J, Li Y.
    J Biochem Mol Toxicol; 2018 Jun 13; 32(6):e22057. PubMed ID: 29687521
    [Abstract] [Full Text] [Related]

  • 37. Synergistic action of the microRNA-17 polycistron and Myc in aggressive cancer development.
    Tagawa H, Karube K, Tsuzuki S, Ohshima K, Seto M.
    Cancer Sci; 2007 Sep 13; 98(9):1482-90. PubMed ID: 17608773
    [Abstract] [Full Text] [Related]

  • 38. miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.
    Liu Z, Zhang G, Yu W, Gao N, Peng J.
    Biochem Biophys Res Commun; 2016 Jan 15; 469(3):692-7. PubMed ID: 26679605
    [Abstract] [Full Text] [Related]

  • 39. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression.
    Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B, Meijer GA.
    Br J Cancer; 2009 Aug 18; 101(4):707-14. PubMed ID: 19672269
    [Abstract] [Full Text] [Related]

  • 40. Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.
    Luo X, Gu J, Zhu R, Feng M, Zhu X, Li Y, Fei J.
    BMC Syst Biol; 2014 Jul 07; 8():82. PubMed ID: 25000828
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.